Bluebird Bio (BLUE) Tops Q2 EPS by 39c

Bluebird Bio (NASDAQ: BLUE) reported Q2 EPS of ($0.06), $0.39 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.15 million.

For earnings history and earnings-related data on Bluebird Bio (BLUE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Playboy to buy back 16.6M shares from Fortress at $1.05 each